The global neurological biomarkers market was valued at USD 9.1 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.9% from 2025 to 2030. Key drivers of this growth include the rising prevalence of neurological disorders and increasing awareness among both physicians and patients. Additionally, advancements in technology and ongoing R&D efforts...